Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity
Publication
, Conference
Brown, MC; Mckay, ZP; Yang, Y; Bigner, DD; Nair, SK; Gromeier, M
Published in: CANCER RESEARCH
2022
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2022
Volume
82
Issue
12
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, M. C., Mckay, Z. P., Yang, Y., Bigner, D. D., Nair, S. K., & Gromeier, M. (2022). Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity. In CANCER RESEARCH (Vol. 82).
Brown, Michael Clavon, Zachary P. Mckay, Yuanfan Yang, Darell D. Bigner, Smita K. Nair, and Matthias Gromeier. “Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity.” In CANCER RESEARCH, Vol. 82, 2022.
Brown MC, Mckay ZP, Yang Y, Bigner DD, Nair SK, Gromeier M. Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity. In: CANCER RESEARCH. 2022.
Brown, Michael Clavon, et al. “Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity.” CANCER RESEARCH, vol. 82, no. 12, 2022.
Brown MC, Mckay ZP, Yang Y, Bigner DD, Nair SK, Gromeier M. Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity. CANCER RESEARCH. 2022.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2022
Volume
82
Issue
12
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis